A detailed history of Marco Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Marco Investment Management LLC holds 22,601 shares of GILD stock, worth $2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
22,601
Previous 21,151 6.86%
Holding current value
$2 Million
Previous $1.55 Million 0.06%
% of portfolio
0.14%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$63.15 - $72.88 $91,567 - $105,676
1,450 Added 6.86%
22,601 $1.55 Million
Q1 2024

May 08, 2024

SELL
$71.58 - $87.29 $342,581 - $417,769
-4,786 Reduced 18.45%
21,151 $1.55 Million
Q4 2023

Feb 05, 2024

BUY
$73.27 - $83.09 $18,390 - $20,855
251 Added 0.98%
25,937 $2.1 Million
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $215,978 - $235,637
-2,921 Reduced 10.21%
25,686 $1.92 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $144,190 - $164,469
-1,897 Reduced 6.22%
28,607 $2.2 Million
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $38,655 - $44,040
-500 Reduced 1.61%
30,504 $2.53 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $140,967 - $202,381
-2,262 Reduced 6.8%
31,004 $2.66 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $199,875 - $228,309
-3,357 Reduced 9.17%
33,266 $2.05 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $199,875 - $228,309
-3,357 Reduced 9.17%
33,266 $2.05 Million
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $147,359 - $165,970
-2,553 Reduced 6.52%
36,623 $2.26 Million
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $616,558 - $772,614
-10,645 Reduced 21.37%
39,176 $2.33 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $90,767 - $103,022
-1,399 Reduced 2.73%
49,821 $3.62 Million
Q3 2021

Nov 10, 2021

SELL
$67.69 - $73.03 $1.94 Million - $2.1 Million
-28,699 Reduced 35.91%
51,220 $3.58 Million
Q2 2021

Aug 11, 2021

BUY
$63.47 - $69.35 $109,612 - $119,767
1,727 Added 2.21%
79,919 $5.5 Million
Q1 2021

May 06, 2021

SELL
$60.0 - $68.46 $33,240 - $37,926
-554 Reduced 0.7%
78,192 $5.05 Million
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $288,801 - $329,075
-5,098 Reduced 6.08%
78,746 $4.59 Million
Q3 2020

Oct 27, 2020

SELL
$62.1 - $78.08 $218,654 - $274,919
-3,521 Reduced 4.03%
83,844 $5.3 Million
Q2 2020

Jul 21, 2020

SELL
$72.34 - $84.0 $359,529 - $417,480
-4,970 Reduced 5.38%
87,365 $6.72 Million
Q1 2020

Apr 17, 2020

SELL
$62.63 - $80.22 $172,295 - $220,685
-2,751 Reduced 2.89%
92,335 $6.9 Million
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $24,524 - $26,976
-398 Reduced 0.42%
95,086 $6.18 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $5,813 - $6,417
93 Added 0.1%
95,484 $6.05 Million
Q2 2019

Aug 06, 2019

BUY
$61.87 - $69.38 $61 - $69
1 Added 0.0%
95,391 $6.45 Million
Q1 2019

May 02, 2019

SELL
$62.53 - $70.05 $392,000 - $439,143
-6,269 Reduced 6.17%
95,390 $6.2 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $6.15 Million - $8.02 Million
-101,541 Reduced 49.97%
101,659 $6.36 Million
Q3 2018

Nov 09, 2018

BUY
$71.28 - $78.92 $168,363 - $186,409
2,362 Added 1.18%
203,200 $15.7 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $39,122 - $45,635
603 Added 0.3%
200,838 $14.2 Million
Q1 2018

May 01, 2018

SELL
$72.84 - $88.8 $211,236 - $257,520
-2,900 Reduced 1.43%
200,235 $15.1 Million
Q4 2017

Feb 15, 2018

BUY
$71.15 - $83.52 $747,288 - $877,210
10,503 Added 5.45%
203,135 $14.6 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $320,312 - $379,657
4,442 Added 2.36%
192,632 $15.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
188,190
188,190 $13.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.